This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/health-28488313

The article has changed 7 times. There is an RSS feed of changes available.

Version 1 Version 2
DNA project 'to make UK world genetic research leader' DNA project 'to make UK world genetic research leader'
(about 2 hours later)
A project aiming to revolutionise medicine by unlocking the secrets of DNA is under way in centres across England.A project aiming to revolutionise medicine by unlocking the secrets of DNA is under way in centres across England.
Prime Minister David Cameron has said it "will see the UK lead the world in genetic research within years".Prime Minister David Cameron has said it "will see the UK lead the world in genetic research within years".
The first genetic codes of people with cancer or rare diseases, out of a target of 100,000, have been sequenced.The first genetic codes of people with cancer or rare diseases, out of a target of 100,000, have been sequenced.
Experts believe it will lead to targeted therapies and could make chemotherapy "a thing of the past".Experts believe it will lead to targeted therapies and could make chemotherapy "a thing of the past".
They argue that understanding DNA will soon play a role in every aspect of medicine from cancer to cardiology.They argue that understanding DNA will soon play a role in every aspect of medicine from cancer to cardiology.
Tumours are caused by mutations in DNA which lead to abnormal cells growing unchecked.Tumours are caused by mutations in DNA which lead to abnormal cells growing unchecked.
Advances in genetics have shown that breast cancer is not one disease but at least 10 - each with a different cause, life expectancy and needing a different treatment.Advances in genetics have shown that breast cancer is not one disease but at least 10 - each with a different cause, life expectancy and needing a different treatment.
Targeted drugs exist such as Herceptin, which is given only if a patient's breast tumour has a certain mutation.Targeted drugs exist such as Herceptin, which is given only if a patient's breast tumour has a certain mutation.
The four-year 100,000 genomes project, run by Genomics England, which was set up for the purpose, is aiming to make such breakthroughs on a massive scale.The four-year 100,000 genomes project, run by Genomics England, which was set up for the purpose, is aiming to make such breakthroughs on a massive scale.
Pilots have been set up at centres across England - including sites in Newcastle, Cambridge and London - and the first genome was sequenced on 30 May.Pilots have been set up at centres across England - including sites in Newcastle, Cambridge and London - and the first genome was sequenced on 30 May.
The project has passed the 100 mark, with the aim of reaching 1,000 by the end of the year and 10,000 by the end of 2015.The project has passed the 100 mark, with the aim of reaching 1,000 by the end of the year and 10,000 by the end of 2015.
Just one human genome contains more than three billion base pairs - the building blocks of DNA.Just one human genome contains more than three billion base pairs - the building blocks of DNA.
It is by looking for subtle differences between genetic codes which lead to disease that researchers believe can fuel the next big breakthroughs.It is by looking for subtle differences between genetic codes which lead to disease that researchers believe can fuel the next big breakthroughs.
The genome of a patient's tumour will be scoured for differences with the genetic code of their healthy tissue.The genome of a patient's tumour will be scoured for differences with the genetic code of their healthy tissue.
People with rare diseases, usually children, will have their DNA compared with that of close relatives.People with rare diseases, usually children, will have their DNA compared with that of close relatives.
University scientists and a drug companies will be allowed to access the data for their research.University scientists and a drug companies will be allowed to access the data for their research.
Case studyCase study
Fifteen thousand families with rare diseases will take part in the project.Fifteen thousand families with rare diseases will take part in the project.
Edward Sherley-Price has first-hand experience of just how little is known about some conditions.Edward Sherley-Price has first-hand experience of just how little is known about some conditions.
His 11-year-old daughter Alysia has regular seizures.His 11-year-old daughter Alysia has regular seizures.
She was diagnosed with a developmental delay before her second birthday, but the cause was unknown.She was diagnosed with a developmental delay before her second birthday, but the cause was unknown.
It took until 2013 for genetic testing to discover what was wrong - a rare genetic mutation known as STXBP1.It took until 2013 for genetic testing to discover what was wrong - a rare genetic mutation known as STXBP1.
The family say getting a diagnosis has given them a renewed sense of optimism.The family say getting a diagnosis has given them a renewed sense of optimism.
The 100,000 Genomes Project could help people like Alysia by identifying a specific mutation, which lead to taking part in future drug trials.The 100,000 Genomes Project could help people like Alysia by identifying a specific mutation, which lead to taking part in future drug trials.
Sir John Chisholm, executive chair of Genomics England, said: "In Britain we were the discoverers of the structure of DNA, we were huge players in the human genome project and now the time has come for the next major step forward.Sir John Chisholm, executive chair of Genomics England, said: "In Britain we were the discoverers of the structure of DNA, we were huge players in the human genome project and now the time has come for the next major step forward.
"One hundred thousand sequences is a very large step; it's a huge commitment.""One hundred thousand sequences is a very large step; it's a huge commitment."
Genomics England will be based at the Wellcome Trust Sanger Institute in Cambridge, which is already a world-recognised centre of genetics research.Genomics England will be based at the Wellcome Trust Sanger Institute in Cambridge, which is already a world-recognised centre of genetics research.
'Every bit of medicine''Every bit of medicine'
Prof Jeremy Farrar, director of the Wellcome Trust, said: "I can see a future where genetics is going to come into every bit of medicine from cardiology to oncology to infectious diseases."Prof Jeremy Farrar, director of the Wellcome Trust, said: "I can see a future where genetics is going to come into every bit of medicine from cardiology to oncology to infectious diseases."
He said there were already targeted therapies for some breast, lung, bowel and blood cancers.He said there were already targeted therapies for some breast, lung, bowel and blood cancers.
"Twenty years from now there's going to be a plethora of those, we will have a series of mutations which academics and industry will have developed therapies for, which will be targeted at you and specific for that cancer.""Twenty years from now there's going to be a plethora of those, we will have a series of mutations which academics and industry will have developed therapies for, which will be targeted at you and specific for that cancer."
He said chemotherapy, which attacks all dividing cells in the body, would be replaced with such therapies.He said chemotherapy, which attacks all dividing cells in the body, would be replaced with such therapies.
"We will look back in 20 years' time and think that the thought of blockbuster chemotherapy [as] a thing of the past and we'll look back with historical eyes and think 'Gosh, what an era that was'." "We will look back in 20 years' time and think of blockbuster chemotherapy [as] a thing of the past and we'll think 'Gosh, what an era that was'."
Analysis
By James Gallagher, Health Editor BBC News website
A revolution is taking place in genetics.
The human genome project took more than a decade, an international team of researchers and around £2bn to sequence an entire genetic code.
Now it can take one machine a couple of days and costs around £1,000.
It means some of those dreams of using our genetic code in healthcare are starting to become reality.
It will soon be practical and affordable enough to have your DNA sequenced as part of a diagnosis.
But what about the treatment? For now there are few targeted drugs like Herceptin out there.
It will take projects like this to help academia and industry find the drugs, which mean DNA sequencing can not just identify the problem, but save our lives as well.
BBC News: Science enters $1000 genome era
BBC News: Detailed map of genome function
David Cameron has announced a series of investments across government, industry and charities totalling £300m.David Cameron has announced a series of investments across government, industry and charities totalling £300m.
He said: "This agreement will see the UK lead the world in genetic research within years. He said: "I am determined to do all I can to support the health and scientific sector to unlock the power of DNA, turning an important scientific breakthrough into something that will help deliver better tests, better drugs and above all better care for patients.
"I am determined to do all I can to support the health and scientific sector to unlock the power of DNA, turning an important scientific breakthrough into something that will help deliver better tests, better drugs and above all better care for patients.
"I believe we will be able to transform how devastating diseases are diagnosed and treated in the NHS and across the world.""I believe we will be able to transform how devastating diseases are diagnosed and treated in the NHS and across the world."
NHS England chief executive Simon Stevens said: "The NHS is now set to become one of the world's 'go-to' health services for the development of innovative genomic tests and patient treatments, building on our long track record as the nation that brought humanity antibiotics, vaccines, modern nursing, hip replacements, IVF, CT scanners, and breakthrough discoveries from the circulation of blood to the existence of DNA."NHS England chief executive Simon Stevens said: "The NHS is now set to become one of the world's 'go-to' health services for the development of innovative genomic tests and patient treatments, building on our long track record as the nation that brought humanity antibiotics, vaccines, modern nursing, hip replacements, IVF, CT scanners, and breakthrough discoveries from the circulation of blood to the existence of DNA."
What do you think about this project? Are you one of those taking part in it? You can send us your comments by emailing haveyoursay@bbc.co.uk using the subject line "DNA".What do you think about this project? Are you one of those taking part in it? You can send us your comments by emailing haveyoursay@bbc.co.uk using the subject line "DNA".